BCL2 and cancer: For cancer cells, luteolin-induced apoptosis is associated with luteolin’s ability to induce activation of wild-type p53, to imbalance the Bcl-2 family of proteins, to up-regulate death receptor 5 and to promote STAT3 degradation [51].